AXGN
Axogen, Inc.Company Information
- Company Name
- Axogen, Inc.
- CIK
- CIK0000805928
- Category
- Large accelerated filer
- Ticker: Exchange
- AXGN: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- AXGN
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-08-08
- Last sale
- 2026-09-02
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 511,146
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 50,768,525
- Shares outstanding
- 53,339,258
- Ownership
- 95.18%
Earnings Market Reaction
- Filing date
- 2026-07-29
- Price on filing date
- —
- 1-month reaction
- 21.83%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 95 | 83 | 36 | 24 | 20 | 18 | 28 | 19 | 19 | 16 | 31 | 31 | ||||||
| Restricted Cash | 2 | 2 | 4 | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Short Term Investments | 17 | 19 | 6 | 12 | 10 | 4 | 6 | 6 | 2 | 2 | 0 | 1 | ||||||
| Accounts Receivable Net Current | 34 | 28 | 26 | 31 | 28 | 26 | 24 | 25 | 25 | 24 | 25 | 23 | ||||||
| Inventory Net | 47 | 46 | 42 | 41 | 37 | 36 | 33 | 29 | 28 | 28 | 23 | 23 | ||||||
| Prepaid Expense And Other Assets Current | 6 | 7 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | ||||||
| Assets Current | 200 | 185 | 120 | 114 | 103 | 93 | 99 | 86 | 82 | 79 | 88 | 87 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 82 | 83 | 82 | 82 | 82 | 83 | 85 | 86 | 87 | 88 | 89 | 89 | ||||||
| Operating Lease Right Of Use Asset | 14 | 14 | 13 | 13 | 14 | 14 | 14 | 15 | 15 | 15 | 16 | 14 | ||||||
| Intangible Assets Net Excluding Goodwill | 8 | 7 | 7 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 4 | ||||||
| Other Assets Noncurrent | 1 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 305 | 289 | 222 | 216 | 205 | 196 | 204 | 192 | 189 | 187 | 197 | 195 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 28 | 24 | 21 | 26 | 23 | 20 | 29 | 21 | 22 | 21 | 29 | 26 | ||||||
| Liabilities Current | 30 | 26 | 24 | 28 | 25 | 22 | 31 | 23 | 23 | 23 | 30 | 27 | ||||||
| Long Term Debt Noncurrent | 0 | 0 | 48 | 48 | 48 | 48 | 47 | 47 | 47 | 47 | 47 | 46 | ||||||
| Derivative Liabilities Noncurrent | 0 | 0 | 4 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 4 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Liabilities | 49 | 45 | 93 | 96 | 93 | 91 | 100 | 93 | 93 | 93 | 101 | 97 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 584 | 571 | 435 | 414 | 406 | 400 | 395 | 391 | 385 | 381 | 377 | 375 | ||||||
| Retained Earnings Accumulated Deficit | -328 | -327 | -307 | -294 | -295 | -295 | -291 | -292 | -290 | -288 | -281 | -277 | ||||||
| Stockholders Equity | 256 | 245 | 129 | 121 | 112 | 105 | 104 | 99 | 96 | 93 | 96 | 98 | ||||||
| Liabilities And Stockholders Equity | 305 | 289 | 222 | 216 | 205 | 196 | 204 | 192 | 189 | 187 | 197 | 195 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 54 | 53 | 47 | 46 | 46 | 46 | 44 | 44 | 44 | 44 | 43 | 43 | ||||||
| Shares Outstanding | 54 | 53 | 47 | 46 | 46 | 46 | 44 | 44 | 44 | 44 | 43 | 43 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAxogen, Inc. (AXGN) — SEC Financial Statements & Analysis
Axogen, Inc. (AXGN) is a electromedical & electrotherapeutic apparatus company, incorporated in MN. Axogen, Inc. trades on Nasdaq as: AXGN. Axogen, Inc. (AXGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, Axogen, Inc. carries a market cap of $2.46B, a P/E ratio of -73.44x, a P/B ratio of 9.61x, a P/S ratio of 9.81x, an enterprise value of $2.37B, and an EV/EBITDA multiple of -372.08x. On profitability, it posts a gross margin of 74.56%, an operating margin of -5.12%, a net margin of -13.36%, a Return on Equity (ROE) of -18.21%, a Return on Assets (ROA) of -13.15%, and a Return on Invested Capital (ROIC) of -8.48%. Per share, it reports EPS of $-0.63, diluted EPS of $-0.63, free cash flow per share of $0.16, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 23.57% year-over-year, net income growth of 619.45% year-over-year, and EPS growth of 521.31% year-over-year. On the balance sheet, it maintains a current ratio of 6.60x, a quick ratio of 4.86x, working capital of $170.00M, a debt-to-equity ratio of 0.19x, a debt ratio of 0.16, an interest coverage ratio of -3.08x, free cash flow of $8.60M (TTM), and net debt of $-96.57M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.46B
- P/E TTM
- -73.44x
- EPS TTM
- $-0.63
- P/B TTM
- 9.61x
- ROE TTM
- -18.21%
- ROA TTM
- -13.15%
- Debt To Equity
- 0.19x
- Free Cash Flow TTM
- $8.60M
- Net Revenue TTM Growth 1Y
- 23.57%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Axogen, Inc. in?
Axogen, Inc. (AXGN) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does AXGN trade on?
Axogen, Inc. (AXGN) trades on the Nasdaq.
Where is Axogen, Inc. incorporated?
Axogen, Inc. is incorporated in MN.
When was Axogen, Inc. (AXGN)'s most recent SEC filing?
Axogen, Inc. (AXGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29.
What is AXGN's market cap?
Axogen, Inc. (AXGN) has a market capitalization of $2.46B as of 2026-06-30.
What is AXGN's EPS (earnings per share)?
Axogen, Inc. (AXGN)'s trailing twelve month EPS is $-0.63 as of 2026-06-30.
What is AXGN's ROE (return on equity)?
Axogen, Inc. (AXGN)'s trailing twelve month Return on Equity (ROE) is -18.21% as of 2026-06-30.
What is AXGN's ROA (return on assets)?
Axogen, Inc. (AXGN)'s trailing twelve month Return on Assets (ROA) is -13.15% as of 2026-06-30.
What is AXGN's ROIC (return on invested capital)?
Axogen, Inc. (AXGN)'s trailing twelve month Return on Invested Capital (ROIC) is -8.48% as of 2026-06-30.
What is AXGN's EV/EBITDA?
Axogen, Inc. (AXGN)'s trailing twelve month EV/EBITDA is -372.08x as of 2026-06-30.